Zhejiang Shouxiangu Pharm Co (603896) — Cash Flow-to-Debt Ratio
Zhejiang Shouxiangu Pharm Co (603896) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥20.94 Million could theoretically repay 0% of its total liabilities (CN¥841.89 Million) in one year. See 603896 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shouxiangu Pharm Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Shouxiangu Pharm Co across 14 annual periods. Also explore Zhejiang Shouxiangu Pharm Co annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shouxiangu Pharm Co (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Shouxiangu Pharm Co. For market capitalisation and broader financial context, see Zhejiang Shouxiangu Pharm Co market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥228.07 Million | CN¥1.02 Billion | ▼ -12.4% |
| 2024 | 0.25x | CN¥213.44 Million | CN¥837.17 Million | ▼ -18.8% |
| 2023 | 0.31x | CN¥315.06 Million | CN¥1.00 Billion | ▼ -12.5% |
| 2022 | 0.36x | CN¥341.28 Million | CN¥950.67 Million | ▼ -58.6% |
| 2021 | 0.87x | CN¥296.70 Million | CN¥342.41 Million | ▲ +26.2% |
| 2020 | 0.69x | CN¥256.36 Million | CN¥373.28 Million | ▼ -44.4% |
| 2019 | 1.24x | CN¥207.92 Million | CN¥168.31 Million | ▲ +48.9% |
| 2018 | 0.83x | CN¥171.51 Million | CN¥206.79 Million | ▼ -57.6% |
| 2017 | 1.96x | CN¥110.80 Million | CN¥56.60 Million | ▲ +259.0% |
| 2016 | 0.55x | CN¥95.52 Million | CN¥175.17 Million | ▲ +52.2% |
| 2015 | 0.36x | CN¥85.03 Million | CN¥237.38 Million | ▼ -37.2% |
| 2014 | 0.57x | CN¥102.90 Million | CN¥180.43 Million | ▼ -4.9% |
| 2013 | 0.60x | CN¥65.85 Million | CN¥109.85 Million | ▲ +79.3% |
| 2012 | 0.33x | CN¥45.36 Million | CN¥135.64 Million | — |